Genetically Predicted Circulating Level of C-Reactive Protein Is Not Associated With Prostate Cancer Risk-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genetically Predicted Circulating Level of C-Reactive Protein Is Not Associated With Prostate Cancer Risk

Published:2020-10-14 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

He Chiyu,Qian Yu,Liu Bin,Yang Shaoxue,Ye Ding,Sun Xiaohui,Chen Tianhui,Mao Yingying

Funder

National Natural Science Foundation of China

Natural Science Foundation of Zhejiang Province

Zhejiang Chinese Medical University

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference26 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.;Bray;CA Cancer J Clin.,2018

2. Prevention and early detection of prostate cancer.;Cuzick;Lancet Oncol.,2014

3. Inflammation in prostate carcinogenesis.;De Marzo;Nat Rev Cancer.,2007

4. Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort.;Il’yasova;Cancer Epidemiol Biomarkers Prev.,2005

5. Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: a nested case-control study.;Touvier;Am J Epidemiol.,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses;PLOS Medicine;2024-03-15

2. The association between METS-IR, an indirect index for insulin resistance, and lung cancer risk;European Journal of Public Health;2024-01-31

3. The Role of C-Reactive Protein in the Prognosis of Prostate Cancer: A Meta-Analysis;Journal of Environmental and Public Health;2023-02-02

4. Body fatness associations with cancer: evidence from recent epidemiological studies and future directions;Metabolism;2022-12

5. C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and Mendelian randomization analysis;BMC Medicine;2022-09-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3